SCHEMBL27137272

SCHEMBL27137272

Cc1cc(Cl)cc(-c2ncnn3cc(CN4C(=O)C5C(C4=O)C5(C)C)cc23)c1CN1CCNCC1C

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ USP7 Q93009 11/20 0.46
▸ KCNH2 Q12809 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30781164 1.00 USP7 (0.46) USP7KCNH2
SCHEMBL27118575 1.00 USP7 (0.46) USP7KCNH2
Hydrochloric Acid SCHEMBL27143446 0.99 USP7 (0.45) USP7KCNH2
Hydrochloric Acid SCHEMBL27143450 0.99 USP7 (0.45) USP7KCNH2
Hydrochloric Acid SCHEMBL30781417 0.99 USP7 (0.45) USP7KCNH2
SCHEMBL30781199 0.90 USP7 (0.43) USP7KCNH2
SCHEMBL27121880 0.90 USP7 (0.43) USP7KCNH2
SCHEMBL27121106 0.90 USP7 (0.45) USP7KCNH2
Hydrochloric Acid SCHEMBL30781332 0.89 USP7 (0.42) USP7KCNH2
Hydrochloric Acid SCHEMBL27149939 0.89 USP7 (0.42) USP7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 — — US claimed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 — — WO claimed
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 — — US disclosed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240150362-A1 Substituted Pyrrolotriazines USP7, UBA7, USP5 USP7 1/4885KCNH2 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback